Clinical Trials for AKI: Lessons Learned From the ARDS Network

Kathleen D Liu

doi:10.1016/j.semnephrol.2020.02.001

Clinical Trials for AKI: Lessons Learned From the ARDS Network

Semin Nephrol. 2020 Mar;40(2):243-246. doi: 10.1016/j.semnephrol.2020.02.001.

Author

Kathleen D Liu¹

Affiliation

¹ Division of Nephrology, Division of Critical Care Medicine, Department of Medicine, Department of Anesthesia, University of California, San Francisco, CA. Electronic address: Kathleen.liu@ucsf.edu.

PMID: 32303286
DOI: 10.1016/j.semnephrol.2020.02.001

Abstract

The acute respiratory distress syndrome and acute kidney injury are both heterogeneous disease syndromes. A large number of multicenter clinical trials have been conducted focused on the treatment and prevention of the acute respiratory distress syndrome. Here, we focus on potential lessons learned for acute kidney injury clinical trials.

Keywords: Acute kidney injury; acute respiratory distress syndrome; clinical trials; prevention; treatment.

Publication types

Review

MeSH terms

Acute Kidney Injury / physiopathology
Acute Kidney Injury / prevention & control*
Acute Kidney Injury / therapy
Clinical Trials as Topic*
Humans
Outcome Assessment, Health Care
Research Design
Respiratory Distress Syndrome / physiopathology
Respiratory Distress Syndrome / prevention & control*
Respiratory Distress Syndrome / therapy